The present invention is directed to a compound represented by the following structural formula:or a pharmaceutically acceptable salt thereof. Pharmaceutical composition comprising a compound represented by Strucutral Formula (I) and method of use of these compound for inhibiting BACE activity in a subject in need of such treatment are also described.
申请公布号
WO2010021680(A3)
申请公布日期
2010.04.15
申请号
WO2009US04686
申请日期
2009.08.14
申请人
VITAE PHARMACEUTICALS, INC.;DILLARD, LAWRENCE, W.;YUAN, JING;JIA, LANQI;ZHENG, YAJUN
